Skip to main content
Year archive

HWAIL PHARM. CO., LTD — 2019 filings

All 18 regulatory filings released by HWAIL PHARM. CO., LTD (061250) in 2019, sourced directly from the official regulator.

18 Filings
2019 Period
2019 filings (18)
Filing Released Lang
현금ㆍ현물배당결정
Notice of Dividend Amount
2019-12-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-12-27 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2019-12-26 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2019-12-18 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2019-12-16 Korean
분기보고서 (2019.09)
Interim / Quarterly Report 9M 2019
2019-11-14 Korean
반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-14 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Q1 2019
2019-05-15 Korean
사업보고서 (2018.12)
Annual Report FY 2018
2019-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2019-03-22 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2019-03-22 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2019-03-22 Korean
감사보고서제출
Audit Report / Information FY 2018
2019-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2019-03-07 Korean
주주총회집중일개최사유신고
AGM Information
2019-03-07 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2019-03-07 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2019-03-07 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2018
2019-02-07 Korean